Pradiksi Gunatama Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Pradiksi Gunatama Tbk. trades at Rp7,450 (market cap 42.89T, 9.5K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Pradiksi Gunatama Tbk. is far larger — about 91.1× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 9.5K). Which is the better fit depends on your goals.
| PGUN | PRDL | |
|---|---|---|
Market Cap | 42.89T | 470.58B |
Volume | 9.5K | 28.43M |
Lot | 95 | 284.34K |
Turnover | 71.21M | 7.8B |
Average Price | 7,495.53 | 274.19 |
Value | 71.21M | 7.8B |
Indicative Equilibrium Price | 7,450 | 270 |
Indicative Equilibrium Volume | 7 | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Pradiksi Gunatama Tbk (Company), was established on September 11, 1995 in the Republic of Indonesia in the framework of foreign investment in accordance with the Domestic Investment Law No. 1 of 1989, Juncto Law No. 12 of 1970, based on deed No. 46 dated June 21, 1996 notary Ny. Toety Juniarto.SH in Jakarta. The Company commenced commercial operations in 2002.
Read more on PGUN →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →